KVUE Stock Today (Nov. 18, 2025): Shares Slip as Appeals Court Weighs Tylenol Cases; Dividend Cleared; Kimberly‑Clark Deal Spread Persists
At a glance — price & drivers (midday, Nov. 18, 2025) Market action and context KVUE softened today after Monday’s developments in federal litigation tied to claims that prenatal acetaminophen use raises autism risk. A three‑judge appeals panel questioned the lower court’s dismissal of those cases, opening the door to their potential return and keeping headline risk front‑and‑center for the stock. Reuters Overnight and early‑morning coverage underscored the legal pressure, noting KVUE fell as the court weighed revival of the suits—sentiment that carried into today’s trading. Bloomberg Law Dividend: payout still on track for Nov. 26 In a separate Texas